On the other hand, in ovarian cancer, it had been observed that the BORIS (Brother of the Regulator of Imprinted Sites) transcription factor downregulates both AR and NIBAN1 expression (Salgado-Albarrán et al., 2019). Here, NIBAN1 is linked to ovarian cancer.